• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人降钙素受体样受体胞质尾与人降钙素受体活性修饰蛋白 2 复合物的功能。

Function of the cytoplasmic tail of human calcitonin receptor-like receptor in complex with receptor activity-modifying protein 2.

机构信息

Frontier Science Research Center, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan.

出版信息

Biochem Biophys Res Commun. 2010 Feb 12;392(3):380-5. doi: 10.1016/j.bbrc.2010.01.030. Epub 2010 Jan 13.

DOI:10.1016/j.bbrc.2010.01.030
PMID:20074556
Abstract

Receptor activity-modifying protein 2 (RAMP2) enables calcitonin receptor-like receptor (CRLR) to form an adrenomedullin (AM)-specific receptor. Here we investigated the function of the cytoplasmic C-terminal tail (C-tail) of human (h)CRLR by co-transfecting its C-terminal mutants into HEK-293 cells stably expressing hRAMP2. Deleting the C-tail from CRLR disrupted AM-evoked cAMP production or receptor internalization, but did not affect [(125)I]AM binding. We found that CRLR residues 428-439 are required for AM-evoked cAMP production, though deleting this region had little effect on receptor internalization. Moreover, pretreatment with pertussis toxin (100ng/mL) led to significant increases in AM-induced cAMP production via wild-type CRLR/RAMP2 complexes. This effect was canceled by deleting CRLR residues 454-457, suggesting Gi couples to this region. Flow cytometric analysis revealed that CRLR truncation mutants lacking residues in the Ser/Thr-rich region extending from Ser(449) to Ser(467) were unable to undergo AM-induced receptor internalization and, in contrast to the effect on wild-type CRLR, overexpression of GPCR kinases-2, -3 and -4 failed to promote internalization of CRLR mutants lacking residues 449-467. Thus, the hCRLR C-tail is crucial for AM-evoked cAMP production and internalization of the CRLR/RAMP2, while the receptor internalization is dependent on the aforementioned GPCR kinases, but not Gs coupling.

摘要

受体活性修饰蛋白 2(RAMP2)使降钙素受体样受体(CRLR)能够形成肾上腺髓质素(AM)特异性受体。在这里,我们通过将其 C 端突变体共转染到稳定表达 hRAMP2 的 HEK-293 细胞中,研究了人(h)CRLR 胞质 C 端尾部(C 尾)的功能。从 CRLR 中删除 C 尾会破坏 AM 诱导的 cAMP 产生或受体内化,但不影响[(125)I]AM 结合。我们发现 CRLR 残基 428-439 是 AM 诱导 cAMP 产生所必需的,尽管删除该区域对受体内化影响不大。此外,用百日咳毒素(100ng/mL)预处理会导致通过野生型 CRLR/RAMP2 复合物诱导 AM 诱导的 cAMP 产生显著增加。通过删除 CRLR 残基 454-457 消除了这种作用,表明 Gi 偶联到该区域。流式细胞术分析显示,缺乏从 Ser(449)到 Ser(467)延伸的富含 Ser/Thr 区的 CRLR 截断突变体无法进行 AM 诱导的受体内化,与野生型 CRLR 的作用相反,过表达 G 蛋白偶联受体激酶-2、-3 和-4 未能促进缺乏残基 449-467 的 CRLR 突变体的内化。因此,hCRLR C 尾对于 AM 诱导的 cAMP 产生和 CRLR/RAMP2 的内化至关重要,而受体内化取决于上述 GPCR 激酶,而不是 Gs 偶联。

相似文献

1
Function of the cytoplasmic tail of human calcitonin receptor-like receptor in complex with receptor activity-modifying protein 2.人降钙素受体样受体胞质尾与人降钙素受体活性修饰蛋白 2 复合物的功能。
Biochem Biophys Res Commun. 2010 Feb 12;392(3):380-5. doi: 10.1016/j.bbrc.2010.01.030. Epub 2010 Jan 13.
2
Functions of the extracellular histidine residues of receptor activity-modifying proteins vary within adrenomedullin receptors.受体活性修饰蛋白的细胞外组氨酸残基的功能在肾上腺髓质素受体中各不相同。
Biochem Biophys Res Commun. 2008 Dec 5;377(1):109-13. doi: 10.1016/j.bbrc.2008.09.105. Epub 2008 Oct 1.
3
Functions of the cytoplasmic tails of the human receptor activity-modifying protein components of calcitonin gene-related peptide and adrenomedullin receptors.降钙素基因相关肽和肾上腺髓质素受体的人类受体活性修饰蛋白组分的胞质尾的功能。
J Biol Chem. 2006 Mar 17;281(11):7205-13. doi: 10.1074/jbc.M511147200. Epub 2006 Jan 11.
4
Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.鉴定对降钙素基因相关肽、肾上腺髓质素和胰淀素受体功能重要的N端受体活性修饰蛋白残基。
Mol Pharmacol. 2008 Oct;74(4):1059-71. doi: 10.1124/mol.108.047142. Epub 2008 Jul 1.
5
Adrenomedullin increases the expression of calcitonin-like receptor and receptor activity modifying protein 2 mRNA in human microvascular endothelial cells.肾上腺髓质素增加人微血管内皮细胞中降钙素样受体及受体活性修饰蛋白2 mRNA的表达。
J Endocrinol. 2006 Aug;190(2):505-14. doi: 10.1677/joe.1.06806.
6
The seven amino acids of human RAMP2 (86) and RAMP3 (59) are critical for agonist binding to human adrenomedullin receptors.人RAMP2(86个氨基酸)和RAMP3(59个氨基酸)中的七个氨基酸对于激动剂与人肾上腺髓质素受体的结合至关重要。
J Biol Chem. 2001 Dec 28;276(52):49459-65. doi: 10.1074/jbc.M108369200. Epub 2001 Oct 8.
7
Aspartate(69) of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2.降钙素样受体的天冬氨酸(69)与其受体活性修饰蛋白1和-2共同发挥功能表达时是必需的。
Biochem Biophys Res Commun. 2004 Jul 9;319(4):1203-9. doi: 10.1016/j.bbrc.2004.05.103.
8
Characterization of the single transmembrane domain of human receptor activity-modifying protein 3 in adrenomedullin receptor internalization.鉴定人类受体活性修饰蛋白 3 的单次跨膜结构域在肾上腺髓质素受体内化中的作用。
Biochem Biophys Res Commun. 2012 Apr 13;420(3):582-7. doi: 10.1016/j.bbrc.2012.03.037. Epub 2012 Mar 16.
9
Structure-function analysis of helix 8 of human calcitonin receptor-like receptor within the adrenomedullin 1 receptor.人降钙素受体样受体中 8 螺旋结构与肾上腺髓质素 1 型受体的功能分析。
Peptides. 2011 Jan;32(1):144-9. doi: 10.1016/j.peptides.2010.10.005. Epub 2010 Oct 12.
10
Effects of endothelin on adrenomedullin secretion and expression of adrenomedullin receptors in rat cardiomyocytes.内皮素对大鼠心肌细胞中肾上腺髓质素分泌及肾上腺髓质素受体表达的影响。
Biochem Biophys Res Commun. 2001 Sep 14;287(1):264-9. doi: 10.1006/bbrc.2001.5572.

引用本文的文献

1
Determining the Effects of Differential Expression of GRKs and β-arrestins on CLR-RAMP Agonist Bias.确定GRKs和β-抑制蛋白差异表达对CLR-RAMP激动剂偏向性的影响。
Front Physiol. 2022 Mar 29;13:840763. doi: 10.3389/fphys.2022.840763. eCollection 2022.
2
CGRP, adrenomedullin and adrenomedullin 2 display endogenous GPCR agonist bias in primary human cardiovascular cells.降钙素基因相关肽、肾上腺髓质素和肾上腺髓质素 2 在原代人心血管细胞中表现出内源性 GPCR 激动剂偏向性。
Commun Biol. 2021 Jun 23;4(1):776. doi: 10.1038/s42003-021-02293-w.
3
Loss of receptor activity-modifying protein 2 in mice causes placental dysfunction and alters PTH1R regulation.
小鼠中受体活性修饰蛋白2的缺失会导致胎盘功能障碍并改变甲状旁腺激素1型受体(PTH1R)的调节。
PLoS One. 2017 Jul 20;12(7):e0181597. doi: 10.1371/journal.pone.0181597. eCollection 2017.
4
Receptor Activity-modifying Protein-directed G Protein Signaling Specificity for the Calcitonin Gene-related Peptide Family of Receptors.受体活性修饰蛋白对降钙素基因相关肽受体家族的G蛋白信号传导特异性的导向作用
J Biol Chem. 2016 Oct 14;291(42):21925-21944. doi: 10.1074/jbc.M116.751362. Epub 2016 Aug 26.
5
Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles.受体活性调节蛋白(RAMPs):新见解与作用
Annu Rev Pharmacol Toxicol. 2016;56:469-87. doi: 10.1146/annurev-pharmtox-010715-103120. Epub 2015 Oct 23.
6
Direct interactions between calcitonin-like receptor (CLR) and CGRP-receptor component protein (RCP) regulate CGRP receptor signaling.降钙素样受体 (CLR) 和 CGRP 受体成分蛋白 (RCP) 之间的直接相互作用调节 CGRP 受体信号转导。
Endocrinology. 2012 Apr;153(4):1850-60. doi: 10.1210/en.2011-1459. Epub 2012 Feb 7.
7
The third extracellular loop of the human calcitonin receptor-like receptor is crucial for the activation of adrenomedullin signalling.人类降钙素受体样受体的第三个细胞外环对于肾上腺髓质素信号的激活至关重要。
Br J Pharmacol. 2012 May;166(1):137-50. doi: 10.1111/j.1476-5381.2011.01803.x.
8
Calcitonin and calcitonin receptor-like receptors: common themes with family B GPCRs?降钙素和降钙素受体样受体:与 B 族 GPCR 有共同主题?
Br J Pharmacol. 2012 May;166(1):51-65. doi: 10.1111/j.1476-5381.2011.01525.x.